Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Jung Hwan Ji"'
Autor:
Chang Ik Yoon, Jawon Hwang, Dooreh Kim, Jung Hwan Ji, Janghee Lee, Soong June Bae, Joon Jeong, Jee-Suk Chang, Yeona Cho, Hye Sun Lee, Jee Ye Kim, Sung Gwe Ahn
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-11 (2023)
Abstract We investigated a prognostic impact of radiotherapy-induced lymphopenia (RIL) in breast cancer patients treated with breast-conservative surgery (BCS). We included 531 breast cancer patients who were treated with BCS and adjuvant radiotherap
Externí odkaz:
https://doaj.org/article/b9250800fb08420fa142b5e688a5dbe8
Autor:
Jung Hwan Ji, Soong June Bae, Seul‐Gi Kim, Min Hwan Kim, Gun‐Min Kim, Joohyuk Sohn, Joon Jeong, Jee Hung Kim, Sung Gwe Ahn
Publikováno v:
Cancer Medicine, Vol 12, Iss 2, Pp 1409-1417 (2023)
Abstract Grade 3/4 anaemia, which is mainly induced by carboplatin, frequently occurs in patients treated with neoadjuvant docetaxel/carboplatin/trastuzumab/pertuzumab (TCHP). However, dose reduction of carboplatin may raise concerns about the oncolo
Externí odkaz:
https://doaj.org/article/36977867352a46bab6c51ccbc9befe28
Autor:
Seung Eun Lee, Sung Gwe Ahn, Jung Hwan Ji, Yoonwon Kook, Ji Soo Jang, Seung Ho Baek, Joon Jeong, Soong June Bae
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundIt is unclear whether upfront surgery or neoadjuvant chemotherapy is appropriate for first treatment in hormone receptor (HR)-positive human epidermal growth factor receptor 2 (HER2)-negative breast cancer patients with 1–2 suspicious axi
Externí odkaz:
https://doaj.org/article/12eef3bcf68a44968e6c6fe3c5655cc3
Autor:
Sung Gwe Ahn, Soong June Bae, Yoonjung Kim, Jung Hwan Ji, Chihhao Chu, Dooreh Kim, Janghee Lee, Yoon Jin Cha, Kyung-A Lee, Joon Jeong
Publikováno v:
npj Breast Cancer, Vol 8, Iss 1, Pp 1-7 (2022)
Abstract We investigated the patterns of recurrence and primary endocrine resistance according to estrogen receptor (ER) alpha gene (ESR1) mutations, as assessed by digital droplet (dd) PCR, in patients with non-metastatic ER+ breast cancer. We colle
Externí odkaz:
https://doaj.org/article/f9b179b355bf4fc580209e03122c6518
Autor:
Jung Hwan Ji, Soong June Bae, Kyungsoo Kim, Chihhao Chu, Kyung-A Lee, Yoonjung Kim, Jee Hung Kim, Joon Jeong, Sung Gwe Ahn
Publikováno v:
npj Breast Cancer, Vol 8, Iss 1, Pp 1-7 (2022)
Abstract We investigated the association between TP53 mutation and 21-gene recurrence score (RS) in ER-positive/HER2-negative breast cancer (BC) using data from 141 patients who underwent TP53 sequencing and Oncotype DX® tests. We detected TP53 muta
Externí odkaz:
https://doaj.org/article/cf67d71b9ef04f029add763cab589197
Autor:
Sung Gwe Ahn, Soong June Bae, Yoonjung Kim, Jung Hwan Ji, Chihhao Chu, Dooreh Kim, Janghee Lee, Yoon Jin Cha, Kyung-A Lee, Joon Jeong
Publikováno v:
npj Breast Cancer, Vol 8, Iss 1, Pp 1-1 (2022)
Externí odkaz:
https://doaj.org/article/2d946ca5b83d41cdb18bb7b16b9a931b
Autor:
Seul-Gi Kim, Min Hwan Kim, Sejung Park, Gun Min Kim, Jee Hung Kim, Jee Ye Kim, Hyung Seok Park, Seho Park, Byeong Woo Park, Seung Il Kim, Jung Hwan Ji, Joon Jeong, Kabsoo Shin, Jieun Lee, Hyung-Don Kim, Kyung Hae Jung, Joohyuk Sohn
Publikováno v:
Cancer Research and Treatment.
Autor:
Soong June Bae, Sung Gwe Ahn, Eun Ji Park, Na Lae Eun, Jee Hung Kim, Jung Hwan Ji, Yoonwon Kook, Ji Soo Jang, Seung Ho Baek, Yoon Jin Cha, Joon Jeong
Publikováno v:
Radiology. 307
Autor:
Soong June Bae, Jawon Hwang, Janghee Lee, Jung Hwan Ji, Chihhao Chu, Jee Hung Kim, Sung Gwe Ahn, Joon Jeong
Publikováno v:
Cancer Research. 82:P3-12
Purpose Loss of progesterone receptor (PR) expression is a poor prognostic factor in ER+/HER2- breast cancer. A growing body of evidence suggests that PR expression is affected by endogenous estrogen level and modulated by body mass index (BMI). Usin
Autor:
Jung Hwan Ji, Soong June Bae, Seul-Gi Kim, Min Hwan Kim, Gun-Min Kim, Joohyuk Sohn, Jee Hung Kim, Sung Gwe Ahn, Joon Jeong
Publikováno v:
Cancer Research. 82:P2-12
Purpose In the patients treated with neoadjuvant docetaxel/carboplatin/trastuzumab/pertuzumab (TCHP) regimen, grade 3-4 anemia occurs frequently during the treatment course. Anemia develops mainly by cytotoxic drug including carboplatin. By contrast,